Shenzhen SiBionics Co., Ltd. va demander le marquage CE pour SIBIONICS CGM

Pour le bénéfice de centaines de millions de diabétiques SHENZHEN, Chine, 22 mai 2023 /PRNewswire/ — Shenzhen SiBionics Co., Ltd. a annoncé qu’elle demandait le marquage CE, avec l’espoir que SIBIONICS CGM profite ainsi à un plus grand nombre de patients diabétiques et d’institutions médicales, leur apportant une meilleure expérience de surveillance de la glycémie ainsi que des solutions … Read more

TVM Capital Healthcare annonce un investissement de 10 millions d’euros dans DEBx Medical

DEBx Medical innove dans la gestion des plaies chroniques, améliorant la vie de millions de patients. Cet investissement permettra à la société d’étendre sa présence mondiale et de s’implanter dans la région MOAN DUBAÏ, Émirats arabes unis et Amsterdam, 22 mai 2023 /PRNewswire/ — TVM Capital Healthcare, société internationale de capital-investissement spécialisée dans le secteur de la santé et … Read more

TVM Capital Healthcare Announces Euro 10 Million Investment in DEBx Medical

DEBx Medical is innovating the management of chronic wounds, improving the life of millions of patients – the investment will enable the company to expand its global footprint and build a presence in the MENA region DUBAI, UAE and AMSTERDAM, May 22, 2023 /PRNewswire/ — TVM Capital Healthcare, a global specialist healthcare private equity firm … Read more

Lifespin Announces the Launch of its First Commercial Product in Regulated Healthcare

Lifespin™ Amino Acid Profiler – A Comprehensive Amino Acid Panel Based on Lifespin’s AI-Driven Metabolic Profiling Platform REGENSBURG, Germany, May 22, 2023 /PRNewswire/ — Lifespin GmbH, a start-up medical diagnostics company with offices in Regensburg (Germany) and Boston (MA), announced today that it has launched Lifespin™ Amino Acid Profiler (LAAP) – its first commercial product for … Read more

Roche introduces navify® Sample Tracking for labs to track patient test samples before even reaching lab premises

At Worldlab-EuroMedLab, Roche presents navify® Sample Tracking, a digital solution allowing labs to connect to innovative applications that monitor quality and detect errors in patient test samples along the entire journey to the lab. navify Sample Tracking is part of the navify® Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational … Read more

Biochips Market size is set to grow by USD 43,273.01 million from 2022 to 2027; The growing use of personalized medicines to boost the market

NEW YORK, May 22, 2023 /PRNewswire/ — The global biochips market size is estimated to grow by USD 43,273.01 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 25.15% during the forecast period. North America is estimated to account for 41% of the market growth. This is due to the infrastructure, … Read more

Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products

CANTON, Conn., May 22, 2023 /PRNewswire/ — Kelyniam Global (OTC: KLYG), a leading maker of custom cranial implants, today announced results for its quarter ended March 31, 2023. “I’m pleased to announce that Kelyniam has expanded our licensing agreement with Bioplate to allow the Company to sell Osteopore products in select markets in the U.S.  Kelyniam will have the opportunity to sell these unique, … Read more

Un nouvel échographe HD60 de Hisense chez Vaal Radiology, en Afrique du Sud

LE CAP, Afrique du Sud, 22 mai 2023 /PRNewswire/ — Hisense, un fabricant et fournisseur d’appareils électroniques et médicaux de haute performance, a récemment installé un échographe HD60 à Vaal Radiology, un centre d’imagerie médicale situé à Vereeninging, en Afrique du Sud. Ce système d’échographie Doppler couleur est idéal pour diverses applications d’échographie, notamment l’échographie abdominale générale, … Read more

Marketing Authorisation Application for lecanemab submitted in Great Britain: BioArctic

STOCKHOLM, May 22, 2023 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that they have submitted a Marketing Authorisation Application (MAA) for lecanemab, an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2] (AD) with confirmed amyloid pathology in the brain, to the UK Medicines and Healthcare products … Read more

Marketing Authorisation Application for lecanemab submitted in Great Britain: BioArctic

STOCKHOLM, May 22, 2023 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that they have submitted a Marketing Authorisation Application (MAA) for lecanemab, an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2] (AD) with confirmed amyloid pathology in the brain, to the UK Medicines and Healthcare products … Read more